Stocks / Pfizer Inc. (NYSE: PFE) / NYSE:PFE (Pfizer Inc.)About PFEA research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Summary Profile Price History Financials Peer Comparison Share Info Performance Dividends Events Pfizer Inc. (NYSE: PFE) Latest News Company Comment What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer 19 May, 2014 | Mark Stones AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline. Read more » Investing Articles What Could Pfizer-AstraZeneca Be Like? 12 May, 2014 | Prabhat Sakya What might be the positives from this potential takeover? Read more » Company Comment Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning? 10 May, 2014 | Mark Stones AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE) Read more » Investing Articles Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’? 9 May, 2014 | Lisa Walls-Hester Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it… Read more » ❮13
Company Comment What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer 19 May, 2014 | Mark Stones AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline. Read more »
Investing Articles What Could Pfizer-AstraZeneca Be Like? 12 May, 2014 | Prabhat Sakya What might be the positives from this potential takeover? Read more »
Company Comment Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning? 10 May, 2014 | Mark Stones AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE) Read more »
Investing Articles Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’? 9 May, 2014 | Lisa Walls-Hester Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it… Read more »